[go: up one dir, main page]

CZ20011792A3 - Derivát benzo[de]isochinolin-1,3-dionu, způsob jeho přípravy, jeho použití a farmaceutický prostředek, který ho obsahuje - Google Patents

Derivát benzo[de]isochinolin-1,3-dionu, způsob jeho přípravy, jeho použití a farmaceutický prostředek, který ho obsahuje

Info

Publication number
CZ20011792A3
CZ20011792A3 CZ20011792A CZ20011792A CZ20011792A3 CZ 20011792 A3 CZ20011792 A3 CZ 20011792A3 CZ 20011792 A CZ20011792 A CZ 20011792A CZ 20011792 A CZ20011792 A CZ 20011792A CZ 20011792 A3 CZ20011792 A3 CZ 20011792A3
Authority
CZ
Czechia
Prior art keywords
derivative
preparation
isoquinoline
dione
benzo
Prior art date
Application number
CZ20011792A
Other languages
Czech (cs)
English (en)
Inventor
Werner Mederski
Ralf Devant
Gerhard Barnickel
Sabine Bernotat-Danielowski
Guido Melzer
Peter Raddatz
Zhengdong Wu
Daljit Dhanoa
Richard Soll
James Rinker
Todd Graybill
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of CZ20011792A3 publication Critical patent/CZ20011792A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/14Aza-phenalenes, e.g. 1,8-naphthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CZ20011792A 1998-11-25 1999-11-09 Derivát benzo[de]isochinolin-1,3-dionu, způsob jeho přípravy, jeho použití a farmaceutický prostředek, který ho obsahuje CZ20011792A3 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19940998A 1998-11-25 1998-11-25
US40099299A 1999-09-21 1999-09-21

Publications (1)

Publication Number Publication Date
CZ20011792A3 true CZ20011792A3 (cs) 2001-09-12

Family

ID=26894739

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20011792A CZ20011792A3 (cs) 1998-11-25 1999-11-09 Derivát benzo[de]isochinolin-1,3-dionu, způsob jeho přípravy, jeho použití a farmaceutický prostředek, který ho obsahuje

Country Status (15)

Country Link
EP (1) EP1133475A1 (es)
JP (1) JP2002530379A (es)
CN (1) CN1328549A (es)
AR (1) AR029152A1 (es)
AU (1) AU1504900A (es)
BR (1) BR9915611A (es)
CA (1) CA2351348A1 (es)
CZ (1) CZ20011792A3 (es)
HU (1) HUP0104469A3 (es)
ID (1) ID29425A (es)
MX (1) MXPA01005228A (es)
NO (1) NO20012543D0 (es)
PL (1) PL347766A1 (es)
SK (1) SK7012001A3 (es)
WO (1) WO2000031039A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0104236D0 (en) 2001-02-21 2001-04-11 Clariant Int Ltd New dye compounds
GB0104240D0 (en) 2001-02-21 2001-04-11 Clariant Int Ltd Copolymer composition having pigment like properties
GB0419850D0 (en) * 2004-09-07 2004-10-13 Angeletti P Ist Richerche Bio Therapeutic agents
US8097725B2 (en) * 2004-12-03 2012-01-17 Roche Diagnostics Operations, Inc. Luminescent indicator dye and optical sensor
WO2012115945A1 (en) * 2011-02-21 2012-08-30 The Board Of Regents Of The University Of Texas System Viral inhibitors
CN103848787A (zh) * 2012-12-06 2014-06-11 中国科学院大连化学物理研究所 一种荧光探针及其在可逆检测次氯酸中的应用
EP2970227B1 (en) * 2013-03-15 2018-01-10 Alumend, LLC Compositions and methods of using the compositions for plaque softening
CN107417616A (zh) 2013-05-01 2017-12-01 中央研究院 治疗β‑地中海贫血和镰状细胞病的方法和组合物
US20200172489A1 (en) * 2017-05-19 2020-06-04 Dojindo Laboratories Fluorescent compound and autophagy detection reagent using same
CN111253368B (zh) * 2018-11-30 2020-12-25 沈阳药科大学 一类稳定氮氧自由基修饰的萘酰亚胺类化合物及其应用
CN111777557B (zh) * 2020-07-28 2022-11-22 中国科学院上海有机化学研究所 以芳香联苯烯为骨架的新型抗肿瘤先导化合物及其应用
CN113087702B (zh) * 2021-03-29 2022-07-12 苏州大学 一种多功能过氯乙烯衍生物及其制备方法与应用
EP4486726A1 (en) * 2022-03-04 2025-01-08 Jawaharlal Nehru Centre For Advanced Scientific Research Amyloid and associated pathology modulators and methods thereof
CA3265669A1 (en) * 2022-08-22 2024-02-29 Jawaharlal Nehru Centre For Advanced Scientific Research TAU LIQUID-LIQUID PHASE SEPARATION MODULATORS AND ASSOCIATED PROCESSES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE2360705A1 (de) * 1973-12-06 1975-06-26 Hoechst Ag Wasserunloesliche verbindungen, verfahren zu ihrer herstellung und ihre verwendung als farbstoffe
US4200752A (en) * 1978-02-16 1980-04-29 Bertelson Robert C 4-Disubstituted amino, N-substituted naphthalimide dyestuffs
JPS54160977A (en) * 1978-06-09 1979-12-20 Kawasaki Steel Corp Functioning speed changing method by means of operating lever
GB2183667B (en) * 1985-10-29 1989-11-22 Univ Brunel Preparation of amino-1;8-naphthalimides.
DE3614414A1 (de) * 1986-04-29 1987-11-05 Knoll Ag Neue benzo(de)isochinolin-1,3-dione, ihre herstellung und verwendung
US5308773A (en) * 1992-11-16 1994-05-03 Microbiomed Corp. Non-azo 1,8-naphthalimide dyes for the detection and quantitation of a paramagnetic metal cation in a non-aqueous medium
DE19505941A1 (de) * 1995-02-21 1996-08-22 Bayer Ag 1,8-Naphthalimid-Derivate, Verfahren zur Herstellung und ihre Verwendung als Zwischenprodukte
NZ335291A (en) * 1996-10-21 2001-02-23 Allelix Biopharma Neurotrophin antagonist compositions

Also Published As

Publication number Publication date
HUP0104469A2 (hu) 2002-04-29
HUP0104469A3 (en) 2003-06-30
NO20012543L (no) 2001-05-23
CN1328549A (zh) 2001-12-26
SK7012001A3 (en) 2001-11-06
ID29425A (id) 2001-08-30
AR029152A1 (es) 2003-06-18
WO2000031039A1 (en) 2000-06-02
CA2351348A1 (en) 2000-06-02
MXPA01005228A (es) 2002-06-21
NO20012543D0 (no) 2001-05-23
PL347766A1 (en) 2002-04-22
BR9915611A (pt) 2001-08-14
EP1133475A1 (en) 2001-09-19
JP2002530379A (ja) 2002-09-17
AU1504900A (en) 2000-06-13

Similar Documents

Publication Publication Date Title
AP9500712A0 (en) Tetracyclic derivatives, process of preparation and use
CZ20011855A3 (cs) Derivát substituovaného benzimidazolu, způsob jeho přípravy a jeho použití
HUP9900958A3 (en) New derivatives of 2-fluoro-3-de[(2,6-dideoxy-3-c-methyl-3-0-methyl-alfa-l-ribohexopyranosyl)-oxy]-6-0-methyl-3-oxo-erytromycin, and their preparation process
HUP0105480A3 (en) Benzofuran derivatives, process for preparation of the same and uses thereof
IL135375A0 (en) Dihydro and tetrahydroisoquinoline derivatives
IL122854A0 (en) Benzo [g] quinoline derivatives their preparation and pharmaceutical preparation containing them
CZ20011652A3 (cs) Farmaceutický přípravek zahrnující moxifloxacin, způsob výroby a použití tohoto přípravku
CZ20011782A3 (cs) Derivát benzo[de]isochinolin-1,3-dionu, způsob jeho přípravy, jeho použití a farmaceutický prostředek, který ho obsahuje
CZ20011792A3 (cs) Derivát benzo[de]isochinolin-1,3-dionu, způsob jeho přípravy, jeho použití a farmaceutický prostředek, který ho obsahuje
CZ20012130A3 (cs) Piperazinový derivát, způsob jeho výroby a pouľití
PL336710A1 (en) Novel derivatives of imidazo [1,5-a]pyrasine-2,3-dione and method of obtaining them
AU4820599A (en) Safe citrus juice and process for preparation
GB9705035D0 (en) Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
HUP0100743A3 (en) Process for preparation of simvastatin and derivatives thereof
HUP0104819A3 (en) Chroman derivatives, their use intermediate and process for their preparation
MXPA03005855A (es) Metodo para preparacion regioselectiva de benzo[g]quinolin-3-carbonitrilos sustituidos y benzo[g]quinazolinas sustituidas.
IL124060A (en) Process for the preparation of quinoline derivatives and intermediates in said process
HUP0103749A3 (en) Tricyclic delta3-piperidines as pharmaceuticals and process for their preparation
HUP0103311A3 (en) Pyrrolo-izoquinoline, -naphtyridine and benzo [c] pyrrolo-azepine derivatives, process for their preparation and pharmaceutical compositions thereof
IL117537A (en) USE OF BENZO [f] QUINOLINE DERIVATIVES IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR TREATING AND PREVENTING PROSTATIC CANCER
IL127376A (en) BENZO[g] QUINOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
HUP0103569A2 (hu) Új gyógyszerkészítmény és eljárás az előállítására
HUP0001452A3 (en) Novel erythromycin derivatives, method of preparation and application as medicines
SI1056737T1 (en) Process for the preparation of simvastatin and derivatives thereof
SI1175428T1 (en) 3-deoxy-desmycosin derivatives and process for their preparation